The hemoglobin E thalassemias

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 8, 2012, Pages

  Fucharoen, Suthat ^a   Weatherall, David J ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN A; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN E; HEMOGLOBIN F; HEMOGLOBIN H; HYDROXYUREA; MESSENGER RNA; PHENOBARBITAL; PROTEIN MYB; PYRIMIDINE 5' NUCLEOTIDE NUCLEOSIDASE; 5' NUCLEOTIDASE;

ALPHA THALASSEMIA; ARTICLE; BART SYNDROME; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHOLECYSTITIS; CLINICAL FEATURE; CONVULSION; DIABETES MELLITUS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERYTHROCYTE STRUCTURE; EXTRAMEDULLARY HEMATOPOIESIS; GALLSTONE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HEART DISEASE; HEART RATE VARIABILITY; HEMOGLOBIN E BETA THALASSEMIA; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HUMAN; HYPERSPLENISM; HYPERTENSION; HYPOTHYROIDISM; HYPOXEMIA; INFECTION; INHERITANCE; IRON OVERLOAD; JAUNDICE; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY OCCLUSION; SICKLE CELL BETA THALASSEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOEMBOLISM; ADAPTATION; ALTERNATIVE RNA SPLICING; BETA THALASSEMIA; GENETICS; GENOTYPE; METABOLISM; MUTATION; PHENOTYPE; PHYSIOLOGY; REVIEW;

5'-NUCLEOTIDASE; ADAPTATION, PHYSIOLOGICAL; ALPHA-THALASSEMIA; ALTERNATIVE SPLICING; BETA-THALASSEMIA; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMOGLOBIN E; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MUTATION; PHENOTYPE; RNA, MESSENGER;

EID: 84886690091     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a011734     Document Type: Article

References (68)

1. Allen A, Fisher C, Premawardena A, Peto T, Allen S, Arambepola K, Thayalsuthan V, Olivieri N, Weatherall D. 2010. Adaptation to anemia in hemoglobin E-β thalassemia. Blood 116: 5368-5370.
2. Aswapokee N, Aswapokee P, Fucharoen S, Wasi P. 1988a. A study of infective episodes in patients with β-thalassemia/Hb E disease in Thailand. Birth Defects 23: 513-520.
3. Aswapokee P, Aswapokee N, Fucharoen S, Sukroongreung S, Wasi P. 1988b. Severe infection in thalassemia: A prospective study. Birth Defects 23: 521-526.
4. Brittenham G, Olivieri N. 2012. Cold Spring Harb Perspect Med (to be published).
5. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A. 2002. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 70: 100-106.
6. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, et al. 2010. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 467: 318-322.
7. Chandcharoensin-Wilde C, Chairoongruang S, Jitnuson P, Fucharoen S, Vathanopas V. 1988. Gallstones in thalassemia. Birth Defects 23: 263-267.
8. Chernoff AI, Minnich V, Na-Nakorn S, Tuchinda S, Kashamsant C, Chernoff RR. 1956. Studies on hemoglobin E: I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. J Lab Clin Med 47: 490-498.
9. De Chiara B, Crivellaro W, Sara R, Ruffini L, Parolini M, Fesslova V, Carnelli V, Fiorentini C, Parodi O. 2005. Early detection of cardiac dysfunction in thalassemic patients by radionuclide angiography and heart rate variability analysis. Eur J Haematol 74: 517-522.
10. Frischer H, Bowman J. 1975. Hemoglobin E, an oxidatively unstable mutation. J Lab Clin Med 85: 531-539.
11. Fucharoen S, Weatherall DJ. 2009. Hemoglobin E disorders. In Disorders of hemoglobin (ed. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ), pp. 417-433. Cambridge University Press, Cambridge.
12. Fucharoen S, Winichagoon P. 2007. Prevention and control of thalassemia in Asia. Asian Biomed 1: 1-6.
13. Fucharoen S, Youngchaiyud P, Wasi P. 1981. Hypoxaemia and the effect of aspirin in thalassaemia. Southeast Asian J Trop Med Public Health 12: 90-93.
14. Fucharoen S, Winichagoon P, Thonglairuam V. 1988a. Beta-thalassemia associated with α-thalassemia in Thailand. Hemoglobin 12: 581-592.
15. Fucharoen S, Winichagoon P, Thonglairuam V, Wasi P. 1988b. EF Bart's disease: Interaction of the abnormal α-and β-globin genes. Eur J Haematol 40: 75-78.
16. Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, et al. 1996. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease. Blood 87: 887-892.
17. Fucharoen S, Winichagoon P, Wisedpanichkij R, Sae-Ngow B, Sriphanich R, Oncoung W, Muangsapaya W, Chowthaworn J, Kanokpongsakdi S, Bunyaratvej A, et al. 1998. Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. Clin Chem 44: 740-748.
18. Higgs DR. 2012. The molecular basis of α thalassemia. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect a011718.
19. Issaragrisil S. 1994. Bone marrow transplantation in Thailand. Bone Marrow Transplant 13: 721-723.
20. Issaragrisil S, Piankigagum A, Wasi P. 1981. Spinal cord compression in thalassemia. Report of 12 cases and recommendations for treatment. Arch Intern Med 141: 1033-1036.
21. Itano HA, Bergren WR, Sturgeon P. 1954. Identification of a fourth abnormal human hemoglobin. J Am Chem Soc 76: 2278.
22. Jootar P, Fucharoen S. 1990. Cardiac involvement in β-thalassemia/hemoglobin E disease: Clinical and hemodynamic findings. Southeast Asian J Trop Med Public Health 21: 269-273.
23. Leelahavarong P, Chaikledkaew U, Hongeng S, Kasemsup V, Lubell Y, Teerawattananon Y. 2010. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res 10: 209.
24. Minnich V, Na-Nakorn S, Chongchareonsuk S, Kochaseni S. 1954. Mediterranean anemia: A study of 32 cases in Thailand. Blood 9: 1-23.
25. Musallam KM, Taher AT, Rachmilewitz EA. 2012. β-Thalassemia intermedia: A clinical perspective. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a013482.
26. Nienhuis AW, Nathan DG. 2012. Pathophysiology and clinical manifestations of the β thalassemias. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011726.
27. Nuinoon M, Makarasara W, Mushiroda T, Setianingsih I, Wahidiyat PA, SripichaiO, Kumasaka N, Takahashi A, Svasti S, Munkongdee T, et al. 2010. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E. Hum Genet 127: 303-314.
28. O'Donnell A, Premawardhena A, Arambepola M, Allen SJ, Peto TE, Fisher CA, Rees DC, Olivieri NF, Weatherall DJ. 2007. Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc Natl Acad Sci 104: 9440-9444.
29. O'Donnell A, Premawardhena A, Arambepola M, Samaranayake R, Allen SJ, PetoTE, Fisher CA, Cook J, Corran PH, Olivieri NF, et al. 2009. Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci 106: 18716-18721.
30. Olivieri NF, Thayalsuthan V, O'Donnell A, Premawardena A, Rigobon C, MuracaG, Fisher C, Weatherall DJ. 2010. Emerging insights in the management of hemoglobin E β thalassemia. Ann NY Acad Sci 1202: 155-157.
31. Olivieri NF, Thayalasuthan V, Muraca G, Weatherall D, Kim C, PremawardhenaA, Perera A, O'Donnell A, St Pierre T. 2011. Relationship between serum ferritin and liver iron concentration in hemoglobin E thalassemia. 16th Congress of European Hematology Association, London, June 9-12.
32. E-globin gene. Nature 300: 768-769.
33. Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, Siritanaratkul N, Webster HK. 2004. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 57: 23-31.
34. Pootrakul P, Rugkiatsakul R, Wasi P. 1980. Increased transferrin iron saturation in splenectomized thalassaemia patients. Brit J Haematol 46: 143-145.
35. Pootrakul P, Vougsmasa V, Laongpanich P, Wasi P. 1981. Serum ferritin levels in thalassemias and the effect of splenectomy. Acta Haematol 66: 244-250.
36. Premawardhena A, Fisher CA, Fathiu F, de Silva S, Perera W, Peto TE, OlivieriNF, Weatherall DJ. 2001. Genetic determinants of jaundice and gallstones in haemoglobin E β thalassaemia. Lancet 357: 1945-1946.
37. Premawardhena A, Fisher CA, Liu YT, Verma IC, de Silva S, Arambepola M, Clegg JB, Weatherall DJ. 2003. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis 31: 98-101.
38. Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Arambepola M, Perera W, O'Donnell A, Peto TEA, Viprakasit V, Merson L, et al. 2005. Haemoglobin E β thalassaemia in Sri Lanka. Lancet 366: 1467-1470.
39. Rees DC, Duley J, Simmonds HA, Wonke B, Thein SL, Clegg JB, Weatherall DJ. 1996. Interaction of hemoglobin E and pyrimidine 5′ nucleotidase deficiency. Blood 88: 2761-2767.
40. Rees DC, Clegg JB, Weatherall DJ. 1998. Is hemoglobin instability important in the interaction between hemoglobin E and β thalassemia? Blood 92: 2141-2146.
41. Rutjanaprom W, Kanlop N, Charoenkwan P, Sittiwangkul R, Srichairatanakool S, Tantiworawit A, Phrommintikul A, Chattipakorn S, Fucharoen S, Chattipakorn N. 2009. Heart rate variability in β-thalassemia patients. Eur J Haematol 83: 483-489.
42. Sankaran VG, Orkin SH. 2012. The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011643.
43. Sathapatayavongs B, Leelachaikul P, Prachaktam R, Atichartakarn V, Sriphojanart S, Trairatvorakul P, Jirasiritham S, Nontasut S, Eurvilaichit C, FlegelT. 1989. Human pythiosis associated with thalassemia hemoglobinopathy syndrome. J Infect Dis 159: 274-280.
44. Sonakul D, Pacharee P, Laohapand T, Fucharoen S, Wasi P. 1980. Pulmonary artery obstruction in thalassaemia. Southeast Asian J Trop Med Public Health 11: 516-523.
45. Sonakul D, Pacharee P, Wasi P, Fucharoen S. 1984. Cardiac pathology in 47 patients with β thalassaemia/haemoglobin E. Southeast Asian J Trop Med Public Health 15: 554-563.
46. Sonakul D, Pacharee P, Thakerngpol K. 1988. Pathologic findings in 76 autopsy cases of thalassemia. Birth Defects 23: 157-176.
47. Sripichai O, Makarasara W, Munkongdee T, Kumkhaek C, Nuchprayoon I, Chuansumrit A, Chuncharunee S, Chantrakoon N, Boonmongkol P, WinichagoonP, et al. 2008. A scoring system for the classification of β-thalassemia/Hb E disease severity. Am J Hematol 83: 482-484.
48. Thakerngpol K, Sonakul D, Fucharoen S, Vathanopas V, Stitnimankarn T. 1988. Histochemical study of liver tissue from thalassemic patients. Birth Defects 23: 193-198.
49. Thein SL. 2012. Molecular basis of β thalassemia. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect a011700.
50. Thonglairuam V, Winichagoon P, Fucharoen S, Wasi P. 1989. The molecular basis of AE-Bart's disease. Hemoglobin 13: 117-124.
51. Tongsong T, Wanapirak C, Sirivatanapa P, Sanguansermsri T, Sirichotiyakul S, Piyamongkol W, Chanprapaph P. 2000. Prenatal control of severe thalassaemia: Chiang Mai strategy. Prenat Diag 20: 229-234.
52. Traeger J, Wood WG, Clegg JB, Weatherall DJ, Wasi P. 1980. Defective synthesis of Hb E is due to reduced levels of βE mRNA. Nature 288: 497-499.
53. Tubsuwan A, Munkongdee T, Jearawiriyapaisarn N, Boonchoy C, WinichagoonP, Fucharoen S, Svasti S. 2011. Molecular analysis of globin gene expression in different thalassaemia disorders: Individual variation of β(E) pre-mRNA splicing determine disease severity. Brit J Haematol 154: 635-643.
54. Vannasaeng S, Ploybutr S, Visutkul P, Tandhanand S, Suwanik R, Wasi P. 1981. Endocrine function in thalassaemia. Clin Endocrinol (Oxf) 14: 165-173.
55. Vathanopas V, Fucharoen S, Chandrcharoensin-Wilde C, Sukroongreung S, Nilakul C. 1988. Cholecystectomy in thalassemia. Birth Defects 23: 269-273.
56. Vichinsky E. 2012. Natural history and clinical manifestations of the α thalassemias. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011742.
57. Wanachiwanawin W, Thianprasit M, Fucharoen S, Chaiprasert A, Sudasna N, Ayudhya N, Sirithanaratkul N, Piankijagum A. 1993. Fatal arteritis due to Pythium insidiosum infection in patients with thalassaemia. Trans R Soc Trop Med Hyg 87: 296-298.
58. Wasi P, Sookanek M, Pootrakul S, Na-Nakorn S, Suingdumrong A. 1967. Haemoglobin E and α-thalassaemia. Br Med J 4: 29-32.
59. Wasi P, Na-Nakorn S, Pootrakul S, Sookanek M, Disthasongcham P, PornpatkulM, Manich V. 1969. Alpha-and β-thalassemia in Thailand. Ann NY Acad Sci 165: 60-82.
60. Wasi P, Na-Nakorn S, Pootrakul P, Sonakul D, Piankijagum A, Pacharee P. 1978. A syndrome of hypertension, convulsions, and cerebral haemorrhage in thalassaemic patients after multiple blood transfusions. Lancet ii: 602-604.
61. Wasi P, Fucharoen S, Younghchaiyud P, Sonakul D. 1982. Hypoxemia in thalassemia. Birth Defects 18: 213-217.
62. Weatherall DJ, Clegg JB. 2001. The thalassaemia syndromes. Blackwell Science, Oxford.
63. Wickramasinghe SN, Lee MJ. 1997. Observations on the relationship between g-globin chain content and globin chain precipitation in thalassaemic erythroblasts and on the composition of erythroblastic inclusions in Hb E/β-thalassaemia. Eur J Haematol 59: 305-309.
64. Williams TN, Weatherall DJ. 2012. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspecta011692.
65. 0-thalassemia/Hb E disease. Am J Hematol 20: 217-222.
66. Winichagoon P, Fucharoen S, Thonglairoam V, Wasi P. 1987. Different severity of homozygous β-thalassemia among siblings. Hum Genet 76: 296-297.
67. Winichagoon P, Thonglairoam V, Fucharoen S, Wilairat P, Fukimaki Y, Wasi P. 1993. Severity differences in β-thalassaemia haemoglobin E syndromes: Implication of genetic factors. Brit J Haematol 83: 633-639.
68. E-globin mRNA on clinical severity of β-thalassemia/hemoglobin E disease. Southeast Asian J Trop Med Public Health 26: 241-245.